Trials / Sponsors / Durata Therapeutics Inc., an affiliate of Allergan plc
Durata Therapeutics Inc., an affiliate of Allergan plc
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Study on the Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Participants With Osteomyeli Osteomyelitis | Phase 2 | 2016-03-15 |
| Withdrawn | A P3 Comparator Trial in Community Acquired Bacterial Pneumonia Community Acquired Pneumonia | Phase 3 | 2015-11-01 |
| Completed | Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure I Abscess, Wound Infection, Surgical Site Infection | Phase 3 | 2014-04-18 |
| Completed | A Single Dose Study To Investigate The Pharmacokinetics and Safety Of Dalbavancin In Hospitalized Children Age Bacterial Infections. | Phase 1 | 2013-06-01 |
| Completed | Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Abscess, Wound Infection, Surgical Site Infection | Phase 3 | 2011-07-01 |
| Completed | Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Abscess, Wound Infection, Surgical Site Infection | Phase 3 | 2011-03-01 |